Last updated on December 2019

Scalp Cooling in Gynecologic Cancer Patients

Brief description of study

In gynecologic cancers, many common chemotherapy agents can lead to chemotherapy-induced alopecia. Currently scalp cooling is the most well studied preventive measure. However, its acceptability and its impact on patients' QOL in Asian population is unclear.

Detailed Study Description

Dynamic scalp cooling system prevents alopecia by inducing vasoconstriction leading to a reduction of scalp blood flow, thus reducing the delivery of cytotoxic drugs to the hair follicles and reducing follicular metabolic activities. One recent meta-analysis included 10 studies showed that the efficacy was 43% in general.

Clinical Study Identifier: NCT04168242

Find a site near you

Start Over

The University of Hong Kong

Hong Kong, Hong Kong
  Connect »